Christopher A. Alabi's expertise lies in sequence-defined oligomers, drug delivery, antibacterial agents, intracellular probes, programmable materials, and change antibacterial agents to targeted antibiotics.

His research focuses on synthetic methods for the assembly of sequence-defined oligomers, development of macromolecular antibacterial and cell penetrating agents, sequence-structure-function relationships, design and development of intracellular probes for measuring organelle specific enzyme kinetics, and assembly of new sequence-defined macromolecules that can be used to create stimuli-responsive materials